1. Home
  2. SVT vs CTXR Comparison

SVT vs CTXR Comparison

Compare SVT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVT
  • CTXR
  • Stock Information
  • Founded
  • SVT 1959
  • CTXR 2007
  • Country
  • SVT United States
  • CTXR United States
  • Employees
  • SVT N/A
  • CTXR N/A
  • Industry
  • SVT Industrial Machinery/Components
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVT Consumer Discretionary
  • CTXR Health Care
  • Exchange
  • SVT Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • SVT 27.1M
  • CTXR 28.4M
  • IPO Year
  • SVT N/A
  • CTXR N/A
  • Fundamental
  • Price
  • SVT $11.10
  • CTXR $2.51
  • Analyst Decision
  • SVT
  • CTXR Strong Buy
  • Analyst Count
  • SVT 0
  • CTXR 2
  • Target Price
  • SVT N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • SVT 1.1K
  • CTXR 98.5K
  • Earning Date
  • SVT 03-21-2025
  • CTXR 02-18-2025
  • Dividend Yield
  • SVT N/A
  • CTXR N/A
  • EPS Growth
  • SVT N/A
  • CTXR N/A
  • EPS
  • SVT 0.05
  • CTXR N/A
  • Revenue
  • SVT $47,487,000.00
  • CTXR N/A
  • Revenue This Year
  • SVT N/A
  • CTXR N/A
  • Revenue Next Year
  • SVT N/A
  • CTXR $216.25
  • P/E Ratio
  • SVT $235.55
  • CTXR N/A
  • Revenue Growth
  • SVT 19.50
  • CTXR N/A
  • 52 Week Low
  • SVT $10.16
  • CTXR $2.44
  • 52 Week High
  • SVT $13.85
  • CTXR $26.75
  • Technical
  • Relative Strength Index (RSI)
  • SVT 54.17
  • CTXR 33.94
  • Support Level
  • SVT $10.39
  • CTXR $2.60
  • Resistance Level
  • SVT $11.15
  • CTXR $3.40
  • Average True Range (ATR)
  • SVT 0.31
  • CTXR 0.24
  • MACD
  • SVT 0.02
  • CTXR -0.02
  • Stochastic Oscillator
  • SVT 88.35
  • CTXR 8.26

About SVT Servotronics Inc.

Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: